Genentech announced that Tamiflu (oseltamivir phosphate) is available for the 2010-2011 influenza season. Tamiflu is indicated for the treatment of uncomplicated acute illness due to influenza infection in patients ≥1year of age who have been symptomatic for ≤2days and for the prophylaxis of influenza in patients ≥1year of age.

Tamiflu is available as a 75mg capsule for adults, 30mg and 45mg capsules for children, and as an oral suspension for children or patients who have difficultly swallowing capsules.

For more information call (800) 821-8590 or visit www.tamiflu.com.